COMP <GO>
MTD vs LLY // FORWARD P/E MULTIPLE
Mettler-Toledo International Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: MTD 5
— LLY 10
▲ FORWARD P/E MULTIPLE LEADER: LLY
LAST: $1,674.81 (-2.55%) • MKT CAP: $34.44B
forward-pe
36.8x
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
forward-pe
26.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTD VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTD | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.40% | 83.64% | -24.24 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 32.36% | -1.96 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 36.4x | -4.72 | MTD | /valuation <GO> |
| Free Cash Flow Yield | 2.46% | 2.30% | +0.16 | MTD | /fcf-yield <GO> |
| Operating Margin | 26.30% | 40.21% | -13.91 | LLY | /operating-margins <GO> |
| Net Profit Margin | 21.60% | 31.90% | -10.30 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 45.51% | -41.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.09 | 9.29 | +1.80 | MTD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.77% | -0.27 | MTD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 77.9 | -12.45 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.51 | +0.36 | MTD | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 36.8x | 26.3x | +10.55 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.44B | $1.33T | -$1.30T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTD REV | LLY REV | MTD GROSS % | LLY GROSS % | MTD FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $65.18B | 59.4% | 83.0% | $848.6M | $16.81B |
| FY 2024 | $3.87B | $45.04B | 60.1% | 81.3% | $864.4M | $8.82B |
| FY 2023 | $3.79B | $34.12B | 44.0% | 79.3% | $795.4M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTD // BETA 0.87
LLY // BETA 0.51